Literature DB >> 18395750

Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines.

Jiachi Ma1, Hirozumi Sawai, Yoichi Matsuo, Nobuo Ochi, Akira Yasuda, Hiroki Takahashi, Takehiro Wakasugi, Hitoshi Funahashi, Mikinori Sato, Yuji Okada, Hiromitsu Takeyama, Tadao Manabe.   

Abstract

BACKGROUND: To better understand the underlying mechanism of liver metastasis formation in human gastric cancer, we evaluated the angiogenic capabilities of human gastric cancer cell lines with different metastatic potentials as well as the role of interleukin (IL)-1alpha in the angiogenic process.
MATERIALS AND METHODS: Reverse transcription-polymerase chain reaction was used to detect the expression of IL-1alpha and vascular endothelial growth factor (VEGF) mRNA in gastric cancer cell lines with different liver metastatic potentials. Levels of VEGF secreted by human gastric cancer cells were measured by enzyme-linked immunosorbent assay. We also examined how gastric cancer cells with different metastatic potentials influence the proliferation and tube formation of human umbilical vein endothelial cells (HUVECs) using the Premix WST-1 cell proliferation assay system and an angiogenesis assay, respectively.
RESULTS: IL-1alpha expression levels were significantly correlated with liver metastatic potential in gastric cancer cell lines. Levels of VEGF secreted by gastric cancer cells appear to be regulated by IL-1alpha through IL-1 receptor Type 1 and were correlated with liver metastatic potential. Both HUVEC proliferation and tube formation were strongly enhanced by coculture with high liver-metastatic gastric cancer cells and were enhanced to a similar extent by culture in the presence of IL-1alpha. In contrast, blockade of IL-1alpha inhibited both HUVEC proliferation and angiogenesis.
CONCLUSIONS: IL-1alpha may play a role in liver metastasis of gastric cancer via enhanced vascular endothelial cell proliferation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18395750     DOI: 10.1016/j.jss.2007.08.014

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  20 in total

1.  A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer.

Authors:  Xiao-Feng Zeng; Juan Li; Sheng-Bin Li
Journal:  Tumour Biol       Date:  2013-07-31

Review 2.  Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

Authors:  Hironori Tsujimoto; Satoshi Ono; Takashi Ichikura; Yusuke Matsumoto; Junji Yamamoto; Kazuo Hase
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

3.  Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.

Authors:  Vegard Tjomsland; Anna Spångeus; Johanna Välilä; Per Sandström; Kurt Borch; Henrik Druid; Sture Falkmer; Ursula Falkmer; Davorka Messmer; Marie Larsson
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

4.  Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α.

Authors:  Chenchen Feng; Ming Guan; Qiang Ding; Yuanfang Zhang; Haowen Jiang; Hui Wen; Paohsun Wang; Zhong Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

Review 5.  Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.

Authors:  Mannon Geindreau; Mélanie Bruchard; Frédérique Vegran
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

6.  Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia.

Authors:  Wataru Shibata; Shigeo Takaishi; Sureshkumar Muthupalani; D Mark Pritchard; Mark T Whary; Arlin B Rogers; James G Fox; Kelly S Betz; Klaus H Kaestner; Michael Karin; Timothy C Wang
Journal:  Gastroenterology       Date:  2009-12-04       Impact factor: 22.682

7.  Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure.

Authors:  Hui-Chun Huang; Omar Haq; Teruo Utsumi; Supatsri Sethasine; Juan G Abraldes; Roberto J Groszmann; Yasuko Iwakiri
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

8.  Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report.

Authors:  Anna Madej-Michniewicz; Marta Budkowska; Daria Sałata; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

9.  Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cell.

Authors:  Jiachi Ma; Xiaowen Sun; Tiankang Guo; He Su; Quan Chen; Zhenqiang Gong; Jianbo Qi; Xiaodan Zhao
Journal:  Cancer Manag Res       Date:  2017-10-09       Impact factor: 3.989

Review 10.  Potential mechanisms of tumor progression associated with postoperative infectious complications.

Authors:  Hironori Tsujimoto; Minako Kobayashi; Hidekazu Sugasawa; Satoshi Ono; Yoji Kishi; Hideki Ueno
Journal:  Cancer Metastasis Rev       Date:  2021-01-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.